GE HealthCare Technologies Inc. is seeing a positive shift in its stock price as it continues to expand its market presence.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is rising today, gaining 1.76% to close at CA$65.35. This uptick follows significant developments in the company's strategic direction, particularly its recent acquisition announcement.
Advertisement
GE HealthCare Technologies Inc.
GEHC.US
GEHC.US
GE HealthCare Technologies Inc.
WealthAwesomeMarket cap
$29.21B
P/E
14.8x
Div. yield
0.22%
Div. / share
$0.14
52W high
$89.64
52W low
$58.72
1W change
+0.38%
Beta
0.85
Analyst Price Targets
Based on 20 analysts covering GEHC · as of Oct 9, 2026
Wall Street analysts forecast GEHC stock price to rise 29.1% over the next 12 months.
Consensus
Buy4.25 / 5.00
Avg. Target
C$82.90
+29.1% Upside
Previously C$82.79 on Oct 7, 2026
Current Price
C$64.22
Last close
Analyst Breakdown (20 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
19.7%
Annualized
90-Day Vol
34.7%
Annualized
Trend (90d)
+7.0%
Annualized drift
90d Mean
C$65.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$64.75 | C$60.50 – C$69.31 |
| 60 trading days | C$65.29 | C$59.31 – C$71.88 |
| 90 trading days | C$65.84 | C$58.52 – C$74.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors are optimistic about GE HealthCare's growth potential after its acquisition of Sofie Biosciences, which is expected to enhance its capabilities in the radiopharmaceutical market.
1.76% Gain
GE HealthCare's stock increase reflects growing investor confidence in its strategic initiatives and market expansion efforts.
Bull case
The acquisition of Sofie Biosciences for $945 million is set to strengthen GE HealthCare's position in the expanding PET radiopharmaceutical market. This move could drive revenue growth and improve profit margins.
Bear case
Despite the positive momentum, concerns remain about margin erosion and the company's significant debt load, which could affect its financial flexibility in the near term.
Strategic Acquisition Fuels Growth Potential
Advertisement
On October 5, GE HealthCare announced its definitive agreement to acquire Sofie Biosciences, a decision expected to enhance its capabilities in the PET radiopharmaceutical market. This acquisition not only expands GE HealthCare's manufacturing footprint but also positions the company to better meet the rising demand for advanced diagnostic solutions.
Positive Market Response
Following the acquisition announcement, GE HealthCare's stock saw a notable rise, reflecting investor optimism about the company's future growth trajectory. The acquisition is expected to significantly boost revenue and profitability, especially in the high-growth radiopharmaceutical segment.
Financial Health and Future Outlook
Despite these positive developments, GE HealthCare's financial health remains under scrutiny. The company's debt levels and margin pressures could pose challenges ahead. However, with a forward P/E ratio suggesting reasonable valuation, investors are cautiously optimistic about the company's long-term prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
